In particular, NEUROD1 chemical reprogramming has produced dopaminergic neurons from astrocytes in an in vivo PD mouse model, while its overexpression reduced the loss of the dopaminergic neurons associated with PD, thus inducing relief of symptoms [22,24,37,38]. The gene discussed is NEUROD1; the disease is Parkinson disease.